Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.35 |
| ▸ | PPARG | P37231 | 4/20 | 0.35 |
| ▸ | RXFP1 | Q9HBX9 | 4/20 | 0.35 |
| ▸ | NR2E3 | Q9Y5X4 | 4/20 | 0.35 |
| ▸ | NCOR2 | Q9Y618 | 4/20 | 0.35 |
| ▸ | NPSR1 | Q6W5P4 | 3/20 | 0.35 |
| ▸ | LMNA | P02545 | 3/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 3/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.34 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.34 |
| ▸ | PGR | P06401 | 1/20 | 0.34 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.33 |
| ▸ | HTT | P42858 | 3/20 | 0.33 |
| ▸ | MAPT | P10636 | 2/20 | 0.33 |
| ▸ | TSHR | P16473 | 2/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.33 |
| ▸ | HCRTR1 | O43613 | 1/20 | 0.33 |
| ▸ | TP53 | P04637 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20349245 | 1.00 | ALDH1A1 (0.35) | ALDH1A1PPARGRXFP1NR2E3NCOR2 | |
| SCHEMBL19999701 | 1.00 | ALDH1A1 (0.35) | ALDH1A1PPARGRXFP1NR2E3NCOR2 | |
| SCHEMBL19999699 | 0.90 | MEN1 (0.38) | ALDH1A1PPARGRXFP1NR2E3NCOR2 | |
| SCHEMBL21074287 | 0.90 | MEN1 (0.38) | ALDH1A1PPARGRXFP1NR2E3NCOR2 | |
| SCHEMBL21074272 | 0.89 | ALDH1A1 (0.33) | ALDH1A1PPARGRXFP1NR2E3NCOR2 | |
| SCHEMBL19999705 | 0.89 | ALDH1A1 (0.33) | ALDH1A1PPARGRXFP1NR2E3NCOR2 | |
| SCHEMBL24425940 | 0.87 | MAOB (0.34) | — | |
| SCHEMBL11921026 | 0.86 | MEN1 (0.34) | ALDH1A1PPARGRXFP1NR2E3NCOR2 | |
| SCHEMBL13843648 | 0.86 | MEN1 (0.34) | ALDH1A1PPARGRXFP1NR2E3NCOR2 | |
| SCHEMBL23613653 | 0.86 | MEN1 (0.34) | ALDH1A1PPARGRXFP1NR2E3NCOR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220144869-A1 | HETEROLEPTIC CARBENE COMPLEXES AND THE USE THEREOF IN ORGANIC ELECTRONICS | UDC IRELAND LIMITED (IE) | 2022-05-12 | — | — | US | disclosed |
| US-11189806-B2 | Heteroleptic carbene complexes and the use thereof in organic electronics | UDC IRELAND LIMITED (IE) | 2021-11-30 | — | — | US | disclosed |
| EP-3492480-B1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORP (US) | 2021-10-20 | — | — | EP | disclosed |
| US-20200373503-A1 | HETEROLEPTIC CARBENE COMPLEXES AND THE USE THEREOF IN ORGANIC ELECTRONICS | BASF SE (DE) | 2020-11-26 | — | — | US | disclosed |
| EP-3492480-A2 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | Universal Display Corporation (US) | 2019-06-05 | — | — | EP | disclosed |
| EP-2493906-B1 | HETEROLEPTIC CARBEN COMPLEXES AND THEIR USE IN ORGANIG ELECTRONICS | BASF SE (DE) | 2015-10-21 | — | — | EP | disclosed |
| US-20120205645-A1 | HETEROLEPTIC CARBENE COMPLEXES AND THE USE THEREOF IN ORGANIC ELECTRONICS | BASF SE (DE) | 2012-08-16 | — | — | US | disclosed |
| US-20120205645-A1 | HETEROLEPTIC CARBENE COMPLEXES AND THE USE THEREOF IN ORGANIC ELECTRONICS | BASF SE (DE) | 2012-08-16 | — | — | US | disclosed |
| WO-2011051404-A1 | HETEROLEPTIC CARBENE COMPLEXES AND USE THEREOF IN ORGANIC ELECTRONICS | BASF SE (DE) | 2011-05-05 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120205645-A1 | HETEROLEPTIC CARBENE COMPLEXES AND THE USE THEREOF IN ORGANIC ELECTRONICS | OCIAD2, OCIAD1, CLTB | ALDH1A1 3051/4885PPARG 985/4885RXFP1 4773/4885 |
| US-20220144869-A1 | HETEROLEPTIC CARBENE COMPLEXES AND THE USE THEREOF IN ORGANIC ELECTRONICS | OCIAD2, OCIAD1, CLTB | ALDH1A1 3145/4885PPARG 692/4885RXFP1 4734/4885 |
| US-20200373503-A1 | HETEROLEPTIC CARBENE COMPLEXES AND THE USE THEREOF IN ORGANIC ELECTRONICS | OCIAD2, OCIAD1, CLTB | ALDH1A1 3051/4885PPARG 985/4885RXFP1 4773/4885 |
| US-11189806-B2 | Heteroleptic carbene complexes and the use thereof in organic electronics | OCIAD2, OCIAD1, CLTB | ALDH1A1 3051/4885PPARG 985/4885RXFP1 4773/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.